BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Hong Peng, Junying Liu, Min Yang, Shiwen Tong, Wenwei Yin, Hui Tang, Peng Hu, Huaidong Hu, Hong Ren. Efficacy of lamivudine combined with adefovir dipivoxil versus entecavir monotherapy in patients with hepatitis B-associated decompensated cirrhosis: A meta-analysisThe Journal of Clinical Pharmacology 2014; 54(2): 189 doi: 10.1002/jcph.181
2
Qingqing Cai, Kailin Chen, Jie Chen, Shaoxu Wu, Qirong Geng, Huiqiang Huang, Tongyu Lin, Wenqi Jiang, Zhongjun Xia, Huaxin Duan, Huilan Rao, Mengfei Yao, Liyang Hu, Seung Up Kim. The Effect of Prophylactic Lamivudine plus Adefovir Therapy Compared with Lamivudine Alone in Preventing Hepatitis B Reactivation in Lymphoma Patients with High Baseline HBV DNA during ChemotherapyPLOS ONE 2016; 11(10): e0164210 doi: 10.1371/journal.pone.0164210
3
Xiao-Dong Gai, Wei-Feng Wu. Effect of entecavir in the treatment of patients with hepatitis B virus-related compensated and decompensated cirrhosisExperimental and Therapeutic Medicine 2017; 14(4): 3908 doi: 10.3892/etm.2017.4963